Literature DB >> 6192955

B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.

C G Kallenberg, P C Limburg, C Van Slochteren, F J Van der Woude, T H The.   

Abstract

B lymphocyte studies, in vivo and in vitro, were performed in 28 patients with systemic lupus erythematosus (SLE). After immunization with the primary test antigen haemocyanin, a decreased antigen specific humoral immune response was observed for all three Ig classes, irrespective of disease activity or the use of corticosteroids. Levels of antibodies against (recall) viral and nuclear antigens were increased during active disease. The in vitro spontaneous production of IgM and IgG, determined in the supernatant of 8 days cultures by ELISA, was highly increased in patients with active disease (reversely correlated with levels of complement C3, r = 0.74). Pokeweed mitogen-induced synthesis was decreased in all patients. The distribution of T cell subsets (OKT3, Leu 3a and OKT8 positive cells) was not different from controls, irrespective of disease activity. It is concluded that the primary humoral immune response is decreased in SLE, whereas a polyclonally activated B cell appears to be present. The normal T cell subset distribution does not support the primary role of the cell in the state of hyperactivity of the B cell.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192955      PMCID: PMC1535674     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  OBSERVATIONS ON THE NATURAL COURSE OF DISSEMINATED LUPUS ERYTHEMATOSUS.

Authors:  M W ROPES
Journal:  Medicine (Baltimore)       Date:  1964-05       Impact factor: 1.889

2.  Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus.

Authors:  C Morimoto; E L Reinherz; L M Nadler; J A Distaso; A D Steinberg; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1982-02

3.  Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus.

Authors:  M G Beale; G S Nash; M J Bertovich; R P MacDermott
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

4.  Defective B cell function in systemic lupus erythematosus.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

5.  Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.

Authors:  P Tan; G Pang; J D Wilson
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

6.  Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.

Authors:  C G Kallenberg; G W Pastoor; A A Wouda; T H The
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

7.  Spontaneous plaque forming cells in the peripheral blood of patients with systemic lupus erythematosus.

Authors:  A G Wangel; A Milton; J B Egan
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies.

Authors:  N K Damle; S Gupta
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features.

Authors:  J S Smolen; T M Chused; W M Leiserson; J P Reeves; D Alling; A D Steinberg
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

10.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man.

Authors:  J A Ledbetter; R L Evans; M Lipinski; C Cunningham-Rundles; R A Good; L A Herzenberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  20 in total

1.  Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.

Authors:  A Holvast; A Huckriede; J Wilschut; G Horst; J J C De Vries; C A Benne; C G M Kallenberg; M Bijl
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

2.  Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus. Chesapeake Pediatric Nephrology Study Group.

Authors:  M M Moxey-Mims; K Preston; B Fivush; F McCurdy
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

3.  Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

Authors:  E C Böttger; T Hoffmann; U Hadding; D Bitter-Suermann
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 4.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

5.  Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cells.

Authors:  A N Akbar; P J Giardina; M W Hilgartner; R W Grady
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

6.  Reticuloendothelial Fc receptor function in SLE patients. II. Associations with humoral immune response parameters in vivo and in vitro.

Authors:  F J van der Woude; C G Kallenberg; P C Limburg; H Beekhuis; W Ouwehand; M van der Giessen; P J Hoedemaeker; G K van der Hem; T H The
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  HLA phenotype and insulin antibody production.

Authors:  W G Reeves; K Gelsthorpe; P Van der Minne; R Torensma; R B Tattersall
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

8.  Diminished response to an inhibitory signal in lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Salata; J Golbus; B C Richardson
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

9.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

10.  B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.

Authors:  P E Spronk; B T vd Gun; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.